| Valproic acid | Approved Investigational | BTBD17 | 388419 |
downregulated | Valproic Acid results in decreased expression of BTBD17 mRNA | 17q25.1 | |
| Valproic acid | Approved Investigational | BTBD3 | 22903 |
downregulated | Valproic Acid results in decreased expression of BTBD3 mRNA | 20p12.2 | |
| Valproic acid | Approved Investigational | BTBD7 | 55727 |
downregulated | Valproic Acid results in decreased expression of BTBD7 mRNA | 14q32.12 | |
| Valproic acid | Approved Investigational | BTD | 686 |
downregulated | Valproic Acid results in decreased expression of BTD mRNA | 3p25.1 | |
| Valproic acid | Approved Investigational | BTF3L4 | 91408 |
downregulated | Valproic Acid results in decreased expression of BTF3L4 mRNA | 1p32.3 | |
| Valproic acid | Approved Investigational | BTG1 | 694 |
downregulated | Valproic Acid results in decreased expression of BTG1 mRNA | 12q21.33 | |
| Valproic acid | Approved Investigational | BTG3 | 10950 |
upregulated | Valproic Acid results in increased expression of BTG3 mRNA | 21q21.1 | |
| Valproic acid | Approved Investigational | BTN2A1 | 11120 |
downregulated | Valproic Acid results in decreased expression of BTN2A1 mRNA | 6p22.2 | |
| Valproic acid | Approved Investigational | BTN2A2 | 10385 |
upregulated | Valproic Acid results in increased expression of BTN2A2 mRNA | 6p22.2 | |
| Valproic acid | Approved Investigational | BTN3A1 | 11119 |
upregulated | Valproic Acid results in increased expression of BTN3A1 mRNA | 6p22.2 | |
| Valproic acid | Approved Investigational | BTN3A2 | 11118 |
downregulated | Valproic Acid results in decreased expression of BTN3A2 mRNA | 6p22.2 | |
| Valproic acid | Approved Investigational | BTN3A2 | 11118 |
upregulated | Valproic Acid results in increased expression of BTN3A2 mRNA | 6p22.2 | |
| Valproic acid | Approved Investigational | BTN3A3 | 10384 |
downregulated | Valproic Acid results in decreased expression of BTN3A3 mRNA | 6p22.2 | |
| Valproic acid | Approved Investigational | BUB1 | 699 |
downregulated | Valproic Acid results in decreased expression of BUB1 mRNA | 2q13 | |
| Valproic acid | Approved Investigational | BUB1 | 699 |
upregulated | Valproic Acid results in increased expression of BUB1 mRNA | 2q13 | |
| Valproic acid | Approved Investigational | BUB1B | 701 |
downregulated | Valproic Acid results in decreased expression of BUB1B mRNA | 15q15.1 | |
| Valproic acid | Approved Investigational | BUB3 | 9184 |
downregulated | Valproic Acid results in decreased expression of BUB3 mRNA | 10q26.13 | |
| Valproic acid | Approved Investigational | BUD13 | 84811 |
downregulated | Valproic Acid results in decreased expression of BUD13 mRNA | 11q23.3 | |
| Valproic acid | Approved Investigational | BVES | 11149 |
upregulated | Valproic Acid results in increased expression of BVES mRNA | 6q21 | |
| Valproic acid | Approved Investigational | BZW1 | 9689 |
upregulated | Valproic Acid results in increased expression of BZW1 mRNA | 2q33.1 | |
| Valproic acid | Approved Investigational | BZW2 | 28969 |
upregulated | Valproic Acid results in increased expression of BZW2 mRNA | 7p21.1 | |
| Valproic acid | Approved Investigational | C1GALT1 | 56913 |
upregulated | Valproic Acid results in increased expression of C1GALT1 mRNA | 7p22.1-p21.3 | |
| Valproic acid | Approved Investigational | C1QBP | 708 |
upregulated | Valproic Acid results in increased expression of C1QBP mRNA | 17p13.2 | |
| Valproic acid | Approved Investigational | C1QL1 | 10882 |
upregulated | Valproic Acid results in increased expression of C1QL1 mRNA | 17q21.31 | |
| Valproic acid | Approved Investigational | C1QTNF12 | 388581 |
downregulated | Valproic Acid results in decreased expression of C1QTNF12 mRNA | 1p36.33 | |